Баркаган З.С., Мамот А.П., Тараненко И.А. и др. Основы пролонгированной профилактики и терапии тромбоэмболий антикоагулянтами непрямого действия (показания, подбор доз, лабораторный мониторинг). - М., 2004.
Рациональная фармакотерапия сердечно-сосудистых заболеваний: Руководство для практикующих врачей / Под общ. ред. Е.И. Чазова, Ю.Н. Беленкова. - М.: Литтерра, 2006. - 971 с.
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) // JACC. - 2000. - Vol. 36. - P. 970-1062.
Albers G., Dalen J., Laupacis A. et. al. Antithrombotic Therapy in Atrial Fibrillation // Chest. - 2001. - Vol. 119. - P. 194-206.
Camm A. Atrial fibrillation: is there a role for low-molecular-weight heparin? // Clin Cardiol. - 2001. - Vol. 24 (suppl. 3). - P. 115-119.
Hirsh J., Anand S., Halperin J., Fuster V. Guide to Anticoagulant Therapy: Heparin. A Statement for Healthcare Professionals From the American Heart Association // Circulation. - 2001. - Vol. 103. - P. 2994-3018.
Hirsh J., Fuster V., Ansell J., Halperin J. AHH/ACC Foundation Guide to Warfarin Therapy // Circulation. - 2003. - Vol. 107. - P. 1692.
Hurlen M., Abdelnoor M., Smith P. et al. Warfarin, aspirin or both after myocardial infarction // N. Engl. J. Med. - 2002. - Vol. 347. - P. 969-974.
The OASIS-6 Trial Group. Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction. The OASIS-6 Randomized Trial // J.A.M.A. - 2006. - Vol. 295. - P. 1519-1530.
The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation // Eur. Heart J. - 2003. - Vol. 24. - P. 28-66.